Dynacure
dose dependent improvement in muscle structure following protein reduction | Dynacure
Company
Deck Type
IPO
Deck date
July 2021
Slide
15 of 33
Related slides by other companies
BioNTech
Results
May 2020
vaccine program three formats formulation two different antigens | BioNTech
Context Therapeutics
Investor Presentation
September 2022
proteins tight junctions regulate cell barrier and permeability tight junction structure proteins constitute a structural core of along with junction adhesion molecule jam and over proteins have been characterized including cancer of protein expression and function occurs in multiple diseases | Context Therapeutics
Melrose
Investor Presentation
May 2023
delivering on our structures improvement plans | Melrose
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights